DOCS241220P47500
- 0.19
- -0.16-45.71%
Doximity Newsroom
Robust Revenue Growth and Margin Expansion Lifted Doximity (DOCS) in Q3
Jefferies Maintains Doximity(DOCS.US) With Buy Rating, Raises Target Price to $64
Optimistic Outlook on Doximity: Benefiting From Shifts in Pharmaceutical Advertising and Strong Growth Potential
RFK Jr. Impact 'Likely Positive' for Doximity, Says Jefferies
Doximity Is Maintained at Neutral by JP Morgan
Express News | Doximity Inc : JP Morgan Raises Target Price to $48 From $30
3 Momentum Anomaly Stocks to Buy as Election Rally Fizzles
Polen U.S. Small Company Growth Strategy Exited Doximity (DOCS) Due to Multiple Factors
Surging Earnings Estimates Signal Upside for Doximity (DOCS) Stock
Teladoc Started at Buy at Goldman Sachs on Membership, Revenue Growth
Calculating The Fair Value Of Doximity, Inc. (NYSE:DOCS)
Doximity's (NYSE:DOCS) Strong Earnings Are Of Good Quality
Doximity Initiated With a Neutral at Goldman Sachs
Goldman Sachs Initiates Doximity(DOCS.US) With Hold Rating, Announces Target Price $58
Balanced Risk/Reward Scenario Leads to Neutral Stance on Doximity
Doximity(DOCS.US) Officer Sells US$5.84 Million in Common Stock
Baird Maintains Doximity(DOCS.US) With Buy Rating, Raises Target Price to $61
Truist Financial Maintains Doximity(DOCS.US) With Hold Rating
Doximity (DOCS) Gets a Hold From Truist Financial
Express News | Doximity Inc : Truist Securities Raises Target Price to $49 From $35